Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inflammatory and Nested Testicular Sex Cord Tumors: Clinical and Molecular Characterization.

Genes·2026
Same author

19q13 amplification with AKT2 and ERCC2 gains in sarcomatoid carcinoma of the urinary bladder.

Cancer genetics·2026
Same author

MicroRNA prognostic markers for immune checkpoint inhibitor success in urologic cancers.

Immunotherapy·2026
Same author

Maintaining oxaliplatin therapy after hypersensitivity reactions: real-world experience with a desensitisation protocol.

Clinical and experimental medicine·2026
Same author

SKP2 at the crossroads of proliferation and immune evasion: a new target in the tumor microenvironment.

Precision clinical medicine·2025
Same author

Cancer vaccines: advances, hurdles, and future directions.

Exploration of targeted anti-tumor therapy·2025
Same journal

Patient-derived resources for decoding and targeting brain metastases ecosystems.

EMBO molecular medicine·2026
Same journal

Obeticholic acid alleviates lupus pathology by inhibiting T follicular helper cell differentiation.

EMBO molecular medicine·2026
Same journal

OTUB1 non-canonically inhibits TAB2 ubiquitination to govern microglia-mediated neuroinflammation.

EMBO molecular medicine·2026
Same journal

Impaired gephyrin G-domain trimerization and phase separation in a patient with developmental epileptic encephalopathy.

EMBO molecular medicine·2026
Same journal

Single-nuclei UPR profiling by flow cytometry reveals bortezomib resistance mechanisms in multiple myeloma.

EMBO molecular medicine·2026
Same journal

Anle138b ameliorates pathological phenotypes in mouse and cellular models of Huntington's disease.

EMBO molecular medicine·2026
See all related articles

Related Experiment Video

Updated: May 23, 2026

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
08:55

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

Published on: November 30, 2016

Selecting for predisposition to cancer cachexia

Ioannis Gioulbasanis1, Panagiotis J Vlachostergios, Christos N Papandreou

  • 1Department of Medical Oncology, University Hospital of Larissa, University of Thessaly School of Medicine, Larissa, Greece.

EMBO Molecular Medicine
|April 13, 2012
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Last Updated: May 23, 2026

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
08:55

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

Published on: November 30, 2016